Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutières syndrome

Eloy Cuadrado, MacHiel H. Jansen, Jasper Anink, Lidia De Filippis, Angelo L. Vescovi, Colin Watts, Eleonora Aronica, Elly M. Hol, Taco W. Kuijpers

Research output: Contribution to journalArticle

Abstract

Aicardi-Goutières syndrome is a genetically determined infantile encephalopathy, manifesting as progressive microcephaly, psychomotor retardation, and in ∼25% of patients, death in early childhood. Aicardi-Goutières syndrome is caused by mutations in any of the genes encoding TREX1, RNASEH2-A,-B,-C and SAMHD1, with protein dysfunction hypothesized to result in the accumulation of nucleic acids within the cell, thus triggering an autoinflammatory response with increased interferon-α production. Astrocytes have been identified as a major source of interferon-α production in the brains of patients with Aicardi-Goutières syndrome. Here, we study the effect of interferon-α treatment on astrocytes derived from immortalized human neural stem cells. Chronic interferon-α treatment promoted astrocyte activation and a reduction in cell proliferation. Moreover, chronic exposure resulted in an alteration of genes and proteins involved in the stability of white matter (ATF4, eIF2Bα, cathepsin D, cystatin F), an increase of antigen-presenting genes (human leukocyte antigen class I) and downregulation of pro-angiogenic factors and other cytokines (vascular endothelial growth factor and IL-1). Interestingly, withdrawal of interferon-α for 7 days barely reversed these cellular alterations, demonstrating that the interferon-α mediated effects persist over time. We confirmed our in vitro findings using brain samples from patients with Aicardi-Goutières syndrome. Our results support the idea of interferon-α as a key factor in the pathogenesis of Aicardi-Goutières syndrome relating to the observed leukodystrophy and microangiopathy. Because of the sustained interferon-α effect, even after withdrawal, therapeutic targets for Aicardi-Goutières syndrome, and other interferon-α-mediated encephalopathies, may include downstream interferon-α signalling cascade effectors rather than interferon-α alone.

Original languageEnglish
Pages (from-to)245-258
Number of pages14
JournalBrain
Volume136
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Aicardi Syndrome
Astrocytes
Interferons
Brain Diseases
Cystatins
Microcephaly
Cathepsin D
Neural Stem Cells
Angiogenesis Inducing Agents
Brain
HLA Antigens
Interleukin-1
Nucleic Acids
Vascular Endothelial Growth Factor A
Genes

Keywords

  • angiopathy
  • astrocytes
  • interferon
  • leukodystrophy

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Cuadrado, E., Jansen, M. H., Anink, J., De Filippis, L., Vescovi, A. L., Watts, C., ... Kuijpers, T. W. (2013). Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutières syndrome. Brain, 136(1), 245-258. https://doi.org/10.1093/brain/aws321

Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutières syndrome. / Cuadrado, Eloy; Jansen, MacHiel H.; Anink, Jasper; De Filippis, Lidia; Vescovi, Angelo L.; Watts, Colin; Aronica, Eleonora; Hol, Elly M.; Kuijpers, Taco W.

In: Brain, Vol. 136, No. 1, 2013, p. 245-258.

Research output: Contribution to journalArticle

Cuadrado, E, Jansen, MH, Anink, J, De Filippis, L, Vescovi, AL, Watts, C, Aronica, E, Hol, EM & Kuijpers, TW 2013, 'Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutières syndrome', Brain, vol. 136, no. 1, pp. 245-258. https://doi.org/10.1093/brain/aws321
Cuadrado, Eloy ; Jansen, MacHiel H. ; Anink, Jasper ; De Filippis, Lidia ; Vescovi, Angelo L. ; Watts, Colin ; Aronica, Eleonora ; Hol, Elly M. ; Kuijpers, Taco W. / Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutières syndrome. In: Brain. 2013 ; Vol. 136, No. 1. pp. 245-258.
@article{45bc06cbb57e4bb69cb08bf8f212f642,
title = "Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Gouti{\`e}res syndrome",
abstract = "Aicardi-Gouti{\`e}res syndrome is a genetically determined infantile encephalopathy, manifesting as progressive microcephaly, psychomotor retardation, and in ∼25{\%} of patients, death in early childhood. Aicardi-Gouti{\`e}res syndrome is caused by mutations in any of the genes encoding TREX1, RNASEH2-A,-B,-C and SAMHD1, with protein dysfunction hypothesized to result in the accumulation of nucleic acids within the cell, thus triggering an autoinflammatory response with increased interferon-α production. Astrocytes have been identified as a major source of interferon-α production in the brains of patients with Aicardi-Gouti{\`e}res syndrome. Here, we study the effect of interferon-α treatment on astrocytes derived from immortalized human neural stem cells. Chronic interferon-α treatment promoted astrocyte activation and a reduction in cell proliferation. Moreover, chronic exposure resulted in an alteration of genes and proteins involved in the stability of white matter (ATF4, eIF2Bα, cathepsin D, cystatin F), an increase of antigen-presenting genes (human leukocyte antigen class I) and downregulation of pro-angiogenic factors and other cytokines (vascular endothelial growth factor and IL-1). Interestingly, withdrawal of interferon-α for 7 days barely reversed these cellular alterations, demonstrating that the interferon-α mediated effects persist over time. We confirmed our in vitro findings using brain samples from patients with Aicardi-Gouti{\`e}res syndrome. Our results support the idea of interferon-α as a key factor in the pathogenesis of Aicardi-Gouti{\`e}res syndrome relating to the observed leukodystrophy and microangiopathy. Because of the sustained interferon-α effect, even after withdrawal, therapeutic targets for Aicardi-Gouti{\`e}res syndrome, and other interferon-α-mediated encephalopathies, may include downstream interferon-α signalling cascade effectors rather than interferon-α alone.",
keywords = "angiopathy, astrocytes, interferon, leukodystrophy",
author = "Eloy Cuadrado and Jansen, {MacHiel H.} and Jasper Anink and {De Filippis}, Lidia and Vescovi, {Angelo L.} and Colin Watts and Eleonora Aronica and Hol, {Elly M.} and Kuijpers, {Taco W.}",
year = "2013",
doi = "10.1093/brain/aws321",
language = "English",
volume = "136",
pages = "245--258",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutières syndrome

AU - Cuadrado, Eloy

AU - Jansen, MacHiel H.

AU - Anink, Jasper

AU - De Filippis, Lidia

AU - Vescovi, Angelo L.

AU - Watts, Colin

AU - Aronica, Eleonora

AU - Hol, Elly M.

AU - Kuijpers, Taco W.

PY - 2013

Y1 - 2013

N2 - Aicardi-Goutières syndrome is a genetically determined infantile encephalopathy, manifesting as progressive microcephaly, psychomotor retardation, and in ∼25% of patients, death in early childhood. Aicardi-Goutières syndrome is caused by mutations in any of the genes encoding TREX1, RNASEH2-A,-B,-C and SAMHD1, with protein dysfunction hypothesized to result in the accumulation of nucleic acids within the cell, thus triggering an autoinflammatory response with increased interferon-α production. Astrocytes have been identified as a major source of interferon-α production in the brains of patients with Aicardi-Goutières syndrome. Here, we study the effect of interferon-α treatment on astrocytes derived from immortalized human neural stem cells. Chronic interferon-α treatment promoted astrocyte activation and a reduction in cell proliferation. Moreover, chronic exposure resulted in an alteration of genes and proteins involved in the stability of white matter (ATF4, eIF2Bα, cathepsin D, cystatin F), an increase of antigen-presenting genes (human leukocyte antigen class I) and downregulation of pro-angiogenic factors and other cytokines (vascular endothelial growth factor and IL-1). Interestingly, withdrawal of interferon-α for 7 days barely reversed these cellular alterations, demonstrating that the interferon-α mediated effects persist over time. We confirmed our in vitro findings using brain samples from patients with Aicardi-Goutières syndrome. Our results support the idea of interferon-α as a key factor in the pathogenesis of Aicardi-Goutières syndrome relating to the observed leukodystrophy and microangiopathy. Because of the sustained interferon-α effect, even after withdrawal, therapeutic targets for Aicardi-Goutières syndrome, and other interferon-α-mediated encephalopathies, may include downstream interferon-α signalling cascade effectors rather than interferon-α alone.

AB - Aicardi-Goutières syndrome is a genetically determined infantile encephalopathy, manifesting as progressive microcephaly, psychomotor retardation, and in ∼25% of patients, death in early childhood. Aicardi-Goutières syndrome is caused by mutations in any of the genes encoding TREX1, RNASEH2-A,-B,-C and SAMHD1, with protein dysfunction hypothesized to result in the accumulation of nucleic acids within the cell, thus triggering an autoinflammatory response with increased interferon-α production. Astrocytes have been identified as a major source of interferon-α production in the brains of patients with Aicardi-Goutières syndrome. Here, we study the effect of interferon-α treatment on astrocytes derived from immortalized human neural stem cells. Chronic interferon-α treatment promoted astrocyte activation and a reduction in cell proliferation. Moreover, chronic exposure resulted in an alteration of genes and proteins involved in the stability of white matter (ATF4, eIF2Bα, cathepsin D, cystatin F), an increase of antigen-presenting genes (human leukocyte antigen class I) and downregulation of pro-angiogenic factors and other cytokines (vascular endothelial growth factor and IL-1). Interestingly, withdrawal of interferon-α for 7 days barely reversed these cellular alterations, demonstrating that the interferon-α mediated effects persist over time. We confirmed our in vitro findings using brain samples from patients with Aicardi-Goutières syndrome. Our results support the idea of interferon-α as a key factor in the pathogenesis of Aicardi-Goutières syndrome relating to the observed leukodystrophy and microangiopathy. Because of the sustained interferon-α effect, even after withdrawal, therapeutic targets for Aicardi-Goutières syndrome, and other interferon-α-mediated encephalopathies, may include downstream interferon-α signalling cascade effectors rather than interferon-α alone.

KW - angiopathy

KW - astrocytes

KW - interferon

KW - leukodystrophy

UR - http://www.scopus.com/inward/record.url?scp=84873399671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873399671&partnerID=8YFLogxK

U2 - 10.1093/brain/aws321

DO - 10.1093/brain/aws321

M3 - Article

C2 - 23365100

AN - SCOPUS:84873399671

VL - 136

SP - 245

EP - 258

JO - Brain

JF - Brain

SN - 0006-8950

IS - 1

ER -